Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shinnichi Iwai"'
Autor:
Mio Ueda, Minako Akiyama, Shinnichi Iwai, Miho Nagai, Eiichiro Kanda, Yume Nagaoka, Yoshihiko Kanno, Michio Nagaoka, Rie Suzuki, Kakei Ryu, Yoshitaka Miyaoka, Yoshiko Tanaka, Hiroshi Yoshimoto
Publikováno v:
Hemodialysis International. 22:388-393
Introduction: Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50f3d24543183ebe2cdeb34309cc8430
https://doi.org/10.1111/hdi.12620
https://doi.org/10.1111/hdi.12620
Autor:
Yume, Nagaoka, Yoshiko, Tanaka, Hiroshi, Yoshimoto, Rie, Suzuki, Kakei, Ryu, Mio, Ueda, Minako, Akiyama, Miho, Nagai, Yoshitaka, Miyaoka, Eiichiro, Kanda, Shinnichi, Iwai, Michio, Nagaoka, Yoshihiko, Kanno
Publikováno v:
Hemodialysis international. International Symposium on Home Hemodialysis. 22(3)
Topiroxostat, a recently developed xanthine oxidase inhibitor, is expected to have fewer adverse effects than allopurinol because it has different mechanism of action from alloprinol. However, its dosage, usage and safety have not been established in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3a130eacddfd02b2e84617c8b58ad32
https://pubmed.ncbi.nlm.nih.gov/29227568
https://pubmed.ncbi.nlm.nih.gov/29227568
Autor:
Yume NAGAOKA, Yoshiko TANAKA, Hiroshi YOSHIMOTO, Rie SUZUKI, Kakei RYU, Mio UEDA, Minako AKIYAMA, Miho NAGAI, Yoshitaka MIYAOKA, Eiichiro KANDA, Shinnichi IWAI, Michio NAGAOKA, Yoshihiko KANNO
Publikováno v:
Home Hemodialysis International; Jul2018, Vol. 22 Issue 3, p388-393, 6p